Method:
The Pan-American Association of Otorhinolaryngology and Head and Neck Surgery, in partnership with the Ibero American Agency for Development and Assessment of Health Technologies, developed a clinical practice guideline on medical management of acute and chronic rhinosinusitis in adults. This document provides punctual evidence-based recommendations for primary care physicians and otolaryngologists on the medical management of these conditions and complies with evidence-based medicine fundamentals and with well-validated guidelines methodology as recommended by the National Institute for Clinical Excellence, the National Institutes of Health, and The Scottish Intercollegiate Guidelines Network.
Results: This document provides from A Grade to D Grade clinical recommendations for treatment of these conditions. The Guideline Development Group made recommendations based on well-designed, randomized controlled trials and systematic reviews. Some clinical questions could not be answered by high quality research and for these questions a Panel Delphi was conducted to provide clinical guidance. Overall there is a need for well-designed RCTs and economic assessments to answer most of the gaps of knowledge for the treatment of acute and chronic rhinosinusitis.
Conclusion:
This clinical practice guideline provides guidance for the medical treatment of adults with acute and chronic rhinosinusitis.
Rhinology/Allergy Polyp Recurrence Rate in Chronic Rhinosinusitis Phenotypes
Tsuguhisa Nakayama, MD (presenter); Tetsushi Okushi; Daiya Asaka; Shin-Ichi Haruna; Hiroshi Moriyama; Nobuyoshi Otori
Objective: We proposed that chronic rhinosinusitis (CRS) is classified by 4 phenotypes in the previous study. Three phenotypes in the 4 were well classified by nasal polyps and mucosal eosinophil count. In this study we investigated the difference of recurrence rate of nasal polyps after endoscopic sinus surgery between these three phenotypes.
Method: This study was a prospective collecting data and retrospective analysis. All patients were followed up for at least 180 days after endoscopic sinus surgery. We defined mucosal eosinophilia as over 80 eosinophils under high-power magnification. Disease-free survival curves were drawn using the Kaplan-Meier method and compared using logrank test.
Results: A total of 264 of the 375 patients were enrolled in the study. The mean follow-up period was 540.4 days. Polyp recurrence was significantly different between the 3 groups (P = .016). Patients with cluster 4 (eosinophilic CRSwNP) had a higher polyp recurrence rate than cluster 2 (non-eosinophilic CRSwNP; P = .047) and cluster 1 (non-eosinophilic CRSsNP; P = .005). Cluster 1 and cluster 2 had no significant difference (P = .362).
Conclusion:
We demonstrated polyp recurrence rate was different between the three phenotypes.
Rhinology/Allergy Quality of Life in Chronic Rhinosinusitis
Aaron K. Remenschneider, MD (presenter); Ralph B. Metson, MD Objective: 1) Establish baseline characteristics of patients with chronic rhinosinusitis using a novel general quality of life instrument, the European Quality of Life 5-Dimension survey (EQ-5D). 2) Compare patients with chronic rhinosinusitis with healthy individuals and with patients with common chronic medical conditions. Method: From February 2011-2012, preoperative quality of life data were obtained from 225 patients with chronic rhinosinusitis prior to surgery at Massachusetts Eye and Ear Infirmary. Global function as well as to 5 distinct parameters (mobility, self-care, activity, pain, anxiety) were compared against published values for healthy and disease controls.
Results: General quality of life as measured using the EQ-5D visual analog scale revealed that patients with chronic POSTERS rhinosinusitis had significantly lower scores when compared with age matched controls: 72.48 ± 17.22 vs 78.75 ± 14.92 (P < .01), 95% CI (-8.41 to -4.14) . Patients with chronic rhinosinusitis also scored worse on pain/discomfort and anxiety/depression when compared to both healthy controls and individuals with diabetes or cardiovascular disease. (P < .05). Mobility, self-care, and activity level were not significantly impaired in patients with chronic rhinosinusitis.
Conclusion:
Patients with chronic rhinosinusitis have impaired quality of life when compared with healthy controls. Pain/ discomfort and anxiety/depression are significantly worse when compared with healthy patients and those with other comorbidities. As a new and powerful quality of life tool, the EQ-5D appears consistent with previously studied instruments for chronic rhinosinusitis. Method: To induce nasal hypertrophy, 2 sheep received Compound 48-80, and 2 sheep were controls. The right middle turbinate was treated with RFA, the left turbinate with microdebrider. In each group, 1 sheep was sacrificed immediately, the other at 3 weeks. Acoustic rhinometry, endoscopic photography and histologic analysis were performed.
Rhinology/Allergy Radiofrequency and Microdebrider turbinate Reduction in Sheep
Results: Endoscopic treatment of the sheep turbinates was feasible with standard endoscopic telescopes and equipment. There were similar increases in nasal volumes between the microdebrider and RFA groups immediately and at 3 weeks. Histologic analysis revealed that the RFA device resulted in a qualitatively increased amount of mucosal damage when compared to the microdebrider. At 3 weeks there was more squamous metaplasia in the RFA group. Endoscopic evaluation revealed similar effects in turbinate reduction between the two groups. Compound 48-80 resulted in the expected decrease in nasal volume and increase in nasal secretions in one of two sheep.
Conclusion:
This pilot study suggests that the heat-independent method of the microdebrider results in less mucosal injury and squamous metaplasia than RFA. Both methods result in turbinate reduction and increases in nasal volume. Continuation of this pilot study is planned to further define these modalities and the effects of Compound 48-80.
Rhinology/Allergy Recurrent Massive allergic Fungal Sinusitis in Children
Vipin Arora, MS, FIMSA (presenter); P. P. Singh Objective: 1) To evaluate the clinical and radiological profile of massive allergic fungal sinusitis (AFS) in children. 2) To evaluate the efficacy of external open sinus surgery for recurrent massive AFS in children.
Method: Retrospective review of clinical and radiological records at tertiary care university hospital. Twelve pediatric patients (age 9-15 years, mean 13.2 years) of recurrent massive AFS who had skull-base erosion, intracranial extension with unilateral or bilateral intraorbital involvement on CT scan were included in study. All patients had undergone multiple unsuccessful endonasal operations (range, 3-5; mean, 3.8). Patients were operated by bilateral lateral rhinotomy and transfrontal approaches (3), transantral endoscopic approach (7), and combined lateral rhinotomy and transnasal approach (2). All patients received postoperative antibiotics and steroids. Postoperative follow-up was done, and symptoms were evaluated (range, 14-24 months; mean 17.5 months).
Results: Nasal obstruction and discharge were the most common presenting complaints. Aspergillus flavus was the most common fungus isolated. All the patients had subjective improvement of symptoms following surgery. Noncontrast CT scan done at least 1 year following surgery showed recidivism of disease in 8.3% cases.
Conclusion:
Individualized external open sinus surgery for massive AFS is effective management for patients who have undergone repeated unsuccessful endonasal procedures. Rate of recidivisim (8.3 %) is less compared to that reported for endonasal procedures (10-100%). Morbidity, complications and cost of single external procedure for massive AFS is less as compared to repeated endonasal procedures.
